Allergy Therapeutics plc (AGY.L)
GBp 6.4
(0.0%)
GBp 6.4
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 55.19 Million | 59.58 Million | 72.76 Million | 84.33 Million | 78.2 Million | 73.71 Million |
| Cost of Revenue | 25.46 Million | 26.89 Million | 23.81 Million | 22.53 Million | 20.69 Million | 18.37 Million |
| Gross Profit | 29.73 Million | 32.69 Million | 48.95 Million | 61.79 Million | 57.51 Million | 55.33 Million |
| Operating Expenses | 64.99 Million | 67.54 Million | 61.95 Million | 59.15 Million | 53.05 Million | 51.12 Million |
| Selling, General and Administrative Expenses | 42.38 Million | 47.42 Million | 46.29 Million | 46.26 Million | 44.05 Million | 44.78 Million |
| Research and Development Expenses | 22.9 Million | 20.12 Million | 15.65 Million | 12.88 Million | 9 Million | 6.95 Million |
| Other Expenses | -287 Thousand | -856 Thousand | - | - | - | - |
| Cost and Expenses | 90.45 Million | 94.43 Million | 85.76 Million | 81.68 Million | 73.74 Million | 69.5 Million |
| Operating Income | -35.25 Million | -34.85 Million | -13 Million | 2.64 Million | 4.45 Million | -1.83 Million |
| Interest Expense | 3.79 Million | 2.15 Million | 541 Thousand | 386 Thousand | 339 Thousand | 11 Thousand |
| Income Tax Expense | -476 Thousand | 449 Thousand | 379 Thousand | 204 Thousand | 379 Thousand | 826 Thousand |
| Earnings before Tax | -40.69 Million | -42.62 Million | -13.39 Million | 3.09 Million | 7.43 Million | 4.29 Million |
| Net Income | -40.21 Million | -43.07 Million | -13.77 Million | 2.88 Million | 7.05 Million | 3.46 Million |
| Earnings Per Share Basic | -0.01 | -0.06 | -0.02 | 0.00 | 0.01 | 0.01 |
| Earnings Per Share Diluted | -0.01 | -0.06 | -0.02 | 0.00 | 0.01 | 0.01 |
| Weighted Average Shares Outstanding | 3.75 Billion | 669.84 Million | 643.01 Million | 671.31 Million | 672.19 Million | 666.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.75 Billion | 670.35 Million | 642.99 Million | 676.65 Million | 673.49 Million | 669.7 Million |
| Gross Margin | 0.54 | 0.55 | 0.67 | 0.73 | 0.74 | 0.75 |
| EBIT Margin | -0.59 | -0.51 | -0.12 | 0.08 | 0.11 | -0.00 |
| Profit Margin | -0.73 | -0.72 | -0.19 | 0.03 | 0.09 | 0.05 |
| EBITDA | -32.58 Million | -36.24 Million | -8.69 Million | 7.6 Million | 11.68 Million | 5.8 Million |
| Earnings Before Tax Margin | -0.64 | -0.58 | -0.18 | 0.03 | 0.06 | -0.02 |
| Breakdown | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY | 2021 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 33.57 Million | 59.58 Million | 19.68 Million | 39.9 Million | 72.76 Million | 24.07 Million |
| Cost of Revenue | 13.05 Million | 26.89 Million | 12.22 Million | 14.11 Million | 23.81 Million | 10.47 Million |
| Gross Profit | 20.52 Million | 32.69 Million | 7.46 Million | 25.78 Million | 48.95 Million | 13.59 Million |
| Operating Expenses | 32.4 Million | 67.54 Million | 35.4 Million | 33.59 Million | 61.95 Million | 33.74 Million |
| Selling, General and Administrative Expenses | 21.36 Million | - | 23.78 Million | 25.1 Million | - | 23.12 Million |
| Research and Development Expenses | 11.38 Million | - | 11.62 Million | 8.49 Million | - | 10.62 Million |
| Other Expenses | -340 Thousand | - | - | - | - | - |
| Cost and Expenses | 45.45 Million | 94.43 Million | 47.63 Million | 47.71 Million | 85.76 Million | 44.22 Million |
| Operating Income | -11.88 Million | -34.85 Million | -27.94 Million | -7.81 Million | -13 Million | -20.15 Million |
| Interest Expense | 3.18 Million | 2.15 Million | 2.04 Million | 398 Thousand | 541 Thousand | 465 Thousand |
| Income Tax Expense | 735 Thousand | 449 Thousand | 999 Thousand | 306 Thousand | 379 Thousand | 524 Thousand |
| Earnings before Tax | -14.91 Million | -42.62 Million | -33.56 Million | -8.19 Million | -13.39 Million | -19.92 Million |
| Net Income | -15.65 Million | -43.07 Million | -34.56 Million | -8.5 Million | -13.77 Million | -20.44 Million |
| Earnings Per Share Basic | -0.01 | - | -0.02 | -0.01 | - | -0.03 |
| Earnings Per Share Diluted | -0.01 | - | -0.02 | -0.01 | - | -0.03 |
| Weighted Average Shares Outstanding | 2.69 Billion | 1.45 Billion | 1.47 Billion | 1.43 Billion | 1.39 Billion | 644.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.72 Billion | 1.45 Billion | 1.47 Billion | 1.43 Billion | 1.39 Billion | 644.18 Million |
| Gross Margin | 0.61 | 0.55 | 0.38 | 0.65 | 0.67 | 0.56 |
| EBIT Margin | -0.28 | - | -1.31 | -0.14 | - | -0.76 |
| Profit Margin | -0.47 | -0.72 | -1.76 | -0.21 | -0.19 | -0.85 |
| EBITDA | -9.35 Million | - | -25.82 Million | -5.71 Million | - | -18.38 Million |
| Earnings Before Tax Margin | -0.35 | -0.58 | -1.42 | -0.20 | -0.18 | -0.84 |
DLAR
TMOAF
ADD
CYBERMEDIA
TJIPF
4905